Results 21 to 30 of about 122,915 (293)
BMC Pulmonary Medicine, 2020 Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann +10 more
doaj +1 more source
European Journal of Immunology, Volume 53, Issue 1, January 2023., 2023 Modern surgical (technical) possibilities enable pleural macrophage isolation and analyses regardless the person`s age. Transcriptome profiling of macrophages from healthy or sick individuals revealed that these cells express high levels of metallothioneins, metal‐binding proteins that are involved in heavy metal detoxification, antioxidative defense ...
Nagoud Schukfeh +11 more
wiley +1 more source
, 2022 Journal of Cutaneous Immunology and Allergy, Volume 5, Issue 6, Page 227-228, December 2022.
Noritaka Oyama +3 more
wiley +1 more source
Journal of Clinical Apheresis, Volume 37, Issue 6, Page 534-543, December 2022., 2022 Abstract Introduction Therapeutic plasma exchange (TPE) is used for several chronic conditions with little evidence on the efficacy and safety of different choice of replacement fluid. Measurement of haemostasis, particularly in vitro thrombin generation, could play a role in determining the immediate efficacy of different fluid replacement.
Ruchika Kohli +6 more
wiley +1 more source
The Lancet, 1960 The historical background to the disorder is unfolded. It was originally regarded as a dermatological curiosity, and later sarcoidosis was recognized as a disorder diffusely involving most tissues of the body. Clinical syndromes described include those presenting to the dermatologist, ophthalmologist, chest physician and radiologist, gastroenterologist
openaire +8 more sources
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
Frontiers in Immunology, 2020 Sarcoidosis is a heterogeneous disease in terms of presentation, duration, and severity. Due to this heterogeneity, it is difficult to align treatment decisions.
Raisa Kraaijvanger +3 more
semanticscholar +1 more source
PLoS ONE, 2023 IntroductionSarcoidosis is a multiorgan, multisystem chronic disease of unknown etiology and unpredictable course. Health status is reduced in sarcoidosis and assessing it is a difficult multitask effort due to many faces this disease might have ...
Mihailo Stjepanovic +7 more
doaj +1 more source
Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments
Journal of Clinical Medicine, 2020 Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations that commonly affects the pulmonary system and other organs including the eyes, skin, liver, spleen, and lymph nodes. Sarcoidosis usually presents with persistent
Rashi Jain +4 more
semanticscholar +1 more source
Characteristics and management of ocular sarcoidosis
Immunological Medicine, 2022 Sarcoidosis is a chronic inflammatory disease of unknown etiology that affects many systemic organs, including the eye. The eye is the second most frequently affected organ in patients with sarcoidosis after lung disease. Approximately 30–50% of patients
Hiroshi Takase
doaj +1 more source